DRUG
Bright Minds Biosciences
DRUG
DRUG
94 hedge funds and large institutions have $670M invested in Bright Minds Biosciences in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 45 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
27% more funds holding
Funds holding: 74 → 94 (+20)
9.77% more ownership
Funds ownership: 84.64% → 94.41% (+9.8%)
Holders
94
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$39.6M | |
| 2 | +$22.8M | |
| 3 | +$21.3M | |
| 4 |
BlackRock
New York
|
+$18.3M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$17.7M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$7.6M | |
| 3 | -$5.78M | |
| 4 |
SCM
Superstring Capital Management
New York
|
-$2.73M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.94M |
